The New Harvest team travelled to D.C. last week, to participate in the FDA’s much-anticipated public meeting on Foods Produced Using Animal Cell Culture Technology, held on July 12th. Our Executive Director Isha Datar was invited to speak on a panel, and Research Director Kate Krueger delivered a public comment.

Vince Sewalt, Global Lead, Product Stewardship & Regulatory at DuPont Industrial Biosciences shares his insights from the enzyme industry

The US Department of Agriculture is holding a meeting of the Advisory Committee on Biotechnology and 21st Century Agriculture (AC21) from September 8 - 9 in Washington, D.C.New Harvest has submitted a public comment on cellular agriculture to this meeting, which can be read in full below:

On July 14, 2016, New Harvest hosted the first invitation-only workshop for industry, academic and government stakeholders in cellular agriculture.

Isha's reflections on being invited to present to the National Academies of Sciences, Engineering, and Medicine on the regulation of future products of biotechnology.

New Harvest has been invited to participate in an incredible opportunity to shape U.S. regulatory policy for biotechnology products.

Insights From a Community Discussion on FDA Approval of Genetically Engineered AquaAdvantage SalmonAquaAdvantage is a salmon, developed by AquaBounty Inc., that has been genetically enhanced to grow more quickly in order to reach market size quicker than conventional salmon.  On November 19, 2015, AquaBounty announced that it had received approval from the U.S. FDA for production, sale, and human consumption.

Event attendees Benjamin Wurgaft and Kevin Schneider share their thoughts on the MOFAD roundtable event: The Future of Meat.

As reviewed by Linnea Laestadius and Alexandra Sexton